These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


386 related items for PubMed ID: 4940355

  • 1. Dynamics of immunologic enhancement.
    Kaliss N.
    Transplant Proc; 1970 Mar; 2(1):59-67. PubMed ID: 4940355
    [No Abstract] [Full Text] [Related]

  • 2. Immunologic enhancement.
    Snell GD.
    Surg Gynecol Obstet; 1970 Jun; 130(6):1109-19. PubMed ID: 4914604
    [No Abstract] [Full Text] [Related]

  • 3. Mechanisms of immunologic enhancement.
    Amos DB, Cohen I, Klein WJ.
    Transplant Proc; 1970 Mar; 2(1):68-75. PubMed ID: 4107294
    [No Abstract] [Full Text] [Related]

  • 4. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum.
    Monaco AP, Wood ML.
    Transplant Proc; 1970 Dec; 2(4):489-96. PubMed ID: 4939696
    [No Abstract] [Full Text] [Related]

  • 5. The mechanism of immunological enhancement of H-2-incompatible skin grafts in mice.
    Chutná J.
    Transplantation; 1971 Jul; 12(1):28-35. PubMed ID: 4932695
    [No Abstract] [Full Text] [Related]

  • 6. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
    McKenzie IF, Snell GD.
    Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
    [No Abstract] [Full Text] [Related]

  • 7. Humoral antibody in allograft reactions.
    Winn HJ.
    Transplant Proc; 1970 Mar; 2(1):83-91. PubMed ID: 4107296
    [No Abstract] [Full Text] [Related]

  • 8. Attempts to abolish tolerance of skin homografts in mice with x-irradiated plasma from specifically sensitized donors.
    Lubaroff DM, Silvers WK.
    J Immunol; 1971 Apr; 106(4):1122-4. PubMed ID: 4928745
    [No Abstract] [Full Text] [Related]

  • 9. Immunogenetic components of weaker histoincompatibility systems in mice.
    Hildemann WH, Morgan M, Frautnick L.
    Transplant Proc; 1970 Mar; 2(1):24-31. PubMed ID: 4940353
    [No Abstract] [Full Text] [Related]

  • 10. Immunologic enhancement of normal tissue grafts.
    Feldman JD.
    Pathol Annu; 1972 Mar; 7():19-44. PubMed ID: 4114602
    [No Abstract] [Full Text] [Related]

  • 11. Immunological facilitation, a broadening of the concept of the enhancement phenomenon.
    Voisin GA.
    Prog Allergy; 1971 Mar; 15():328-485. PubMed ID: 4151281
    [No Abstract] [Full Text] [Related]

  • 12. Effect of immunosuppression and cellular antigen on xenograft survival.
    Cerilli J, Gideon L, Hattan D.
    Transplant Proc; 1970 Dec; 2(4):516-21. PubMed ID: 4939699
    [No Abstract] [Full Text] [Related]

  • 13. Hyperacute rejection and enhancement of mouse skin grafts by antibodies with a distinct specificity.
    Jansen JL, Koene RA, Kamp GJ, Hagemann JF, Wijdeveld PG.
    J Immunol; 1975 Aug; 115(2):392-4. PubMed ID: 1097512
    [Abstract] [Full Text] [Related]

  • 14. Transplantation tolerance and enhancement. Concepts and questions.
    Elkins WL, Hellström I, Hellström KE.
    Transplantation; 1974 Jul; 18(1):38-45. PubMed ID: 4151912
    [No Abstract] [Full Text] [Related]

  • 15. The role of immunological enhancement for the growth of autochthonous tumors.
    Hellström I, Hellström KE.
    Transplant Proc; 1971 Mar; 3(1):721-4. PubMed ID: 4106337
    [No Abstract] [Full Text] [Related]

  • 16. Soluble mouse histocompatibility antigens.
    Koene R, McKenzie IF, Painter E, Sachs DH, Winn HJ, Russell PS.
    Transplant Proc; 1971 Mar; 3(1):231-3. PubMed ID: 4106314
    [No Abstract] [Full Text] [Related]

  • 17. The present status of tumor immunology.
    Fisher B.
    Adv Surg; 1971 Mar; 5():189-254. PubMed ID: 4941820
    [No Abstract] [Full Text] [Related]

  • 18. Studies of tumor antigens and tumor-specific immune mechanisms in experimental systems.
    Law LW.
    Transplant Proc; 1970 Mar; 2(1):117-32. PubMed ID: 4330038
    [No Abstract] [Full Text] [Related]

  • 19. Tolerance and enhancement in organ transplantation.
    Brent L.
    Transplant Proc; 1972 Sep; 4(3):363-8. PubMed ID: 4404151
    [No Abstract] [Full Text] [Related]

  • 20. Immunogenetic approach to neoplasia.
    Tennant JR.
    Transplant Proc; 1970 Mar; 2(1):104-16. PubMed ID: 4107289
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.